BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2009
View Archived Issues
Dual-action inhibitors of coagulation factor Xa and thrombin reported by Bayer
Read More
New non-nucleoside reverse transcriptase inhibitors in development at GSK
Read More
Novel ERK2 inhibitors with oncolytic properties disclosed by Schering-Plough
Read More
Bristol-Myers Squibb divulges novel coagulation factor XIa and/or plasma kallikrein inhibitors
Read More
New renin inhibitors jointly imparted by Mitsubishi Tanabe Pharma and Shanghai Pharmaceutical
Read More
Theravance submits NDA to FDA for telavancin for nosocomial pneumonia
Read More
EpiCept reports positive results from phase IIb EpiCept trial
Read More
CLK-1 inhibition may explain the effect of clioquinol in neurodegenerative diseases
Read More
Priming with rAd41 vector expressing HIV Env facilitates mucosal immunity in mice
Read More
GSK-3beta inhibition with CU-GTSM improves cognitive function in Alzheimer's disease model
Read More
Altus realigns product development priorities and focuses on ALTU-238
Read More
CytRx reports 2009 clinical and development milestones
Read More
Inspire initiates phase III Prolacria trial under FDA special protocol
Read More
DelSite presents a report on company activities
Read More
DOR BioPharma forms medical advisory board to advise on development of DOR-201
Read More
Schering-Plough completes patient enrollment in phase III SPRINT-2 study of boceprevir
Read More
Sequenom initiates exchange offer to acquire EXACT Sciences for USD 41 million
Read More
Astellas proposes to acquire CV Therapeutics for USD 16 per share in cash
Read More
MHRA grants approval to Cortex to initiate study of CX-1739 in sleep apnea
Read More
Orexo and NovaMed sign licensing and distribution agreement for Abstral in China
Read More
Addex announces successful completion of phase I program of ADX-48621
Read More
ARCA biopharma and Nuvelo merge to create late-stage cardiovascular company
Read More
Callisto redirects atiprimod development to treat rheumatoid arthritis
Read More
FORMA Therapeutics collaborates with Cubist to discover novel antibacterial drugs
Read More
Oncolytics initiates patient enrollment in Reolysin colorectal cancer trial
Read More